Average Co-Inventor Count = 3.38
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (15 from 3,923 patents)
2. Other (2 from 832,680 patents)
17 patents:
1. 12208097 - Protein kinase C inhibitors for treatment of uveal melanoma
2. 11505541 - Protein kinase C inhibitors and methods of their use
3. 11413284 - Protein kinase C inhibitors for treatment of uveal melanoma
4. 11192877 - 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
5. 11059804 - Protein kinase C inhibitors and methods of their use
6. 11053218 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
7. 10647701 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
8. 10640489 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
9. 10508101 - Protein kinase C inhibitors and methods of their use
10. 10414755 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
11. 9845309 - Protein kinase C inhibitors and methods of their use
12. 9452998 - Protein kinase C inhibitors and methods of their use
13. 9181266 - 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
14. 9126979 - Compounds for inhibiting the interaction of BCL2 with binding partners
15. 9126980 - Compounds for inhibiting the interaction of BCL2 with binding partners